VP, Marketing & Global Brand

Your mission

Summary
We are seeking a Vice President, Marketing & Global Brand to own Immunic's global brand strategy and marketing organization as the company prepares for the potential approval and launch of vidofludimus calcium in relapsing MS. This is a builder role for a marketer who has done this before: someone who has led a global brand through an MS launch, understands how positioning, messaging, and channel strategy need to flex across the U.S. and international markets, and can build a marketing function and team from the ground up ahead of a first commercial launch. The role sits at the center of launch planning, working in lockstep with Market Access, Patient Advocacy, Medical Affairs, and Regulatory to ensure the brand strategy reflects both the science and the realities of how the therapy will actually reach patients.

Responsibilities

• Develop and own Immunic's global brand strategy and positioning for vidofludimus calcium in relapsing MS, ensuring a consistent core narrative that can be adapted across U.S. and international markets
• Lead brand architecture, naming, and visual identity decisions in partnership with external agencies and internal stakeholders
• Translate clinical and mechanism-of-action data into a differentiated, patient- and physician-relevant brand story
• Lead marketing's contribution to integrated launch planning, ensuring brand strategy, messaging, and channel plans are ready ahead of anticipated regulatory approval
• Apply lessons learned from prior global MS product launches to Immunic's launch playbook, including sequencing, market prioritization, and pre-launch disease education
• Build and manage the marketing budget and launch investment plan in partnership with Finance and the Chief Operating Officer
• Design and build Immunic's global marketing function from the ground up, including organizational structure, headcount planning, and hiring
• Select, onboard, and manage external agency partners (creative, media, market research, digital) needed to execute at launch quality with a lean internal team
• Establish marketing operating processes and governance that can scale from pre-launch through commercial launch
• Own healthcare provider (HCP) marketing strategy, including scientific and promotional messaging, congress presence, and field marketing support
• Own patient- and caregiver-facing marketing and disease education strategy, working closely with the VP, Patient Advocacy to ensure alignment with the patient support and access strategy
• Lead omnichannel and digital marketing strategy, including web, social, and non-personal promotion, appropriate to a specialty/rare disease launch
• Lead global market research to inform positioning, messaging, and market prioritization decisions ahead of and following launch
• Translate physician, patient, and payer insights into actionable brand and marketing strategy in partnership with Market Access and Medical Affairs
• Partner closely with Market Access, Patient Advocacy, Medical Affairs, Regulatory, and Legal/Compliance to ensure marketing strategy is fully integrated into launch readiness
• Represent the global brand perspective in leadership and launch readiness discussions, balancing global consistency with market-level flexibility
• Coordinate with international colleagues and partners to ensure the brand strategy translates effectively outside the U.S., building on Immunic's operational roots in Germany

Your profile

Qualifications & Education

• Bachelor's degree required; MBA or advanced degree preferred
• 15+ years of progressive marketing experience in biotechnology or pharmaceuticals, with significant experience in brand and global marketing leadership roles
• Direct experience leading global brand strategy and marketing through the launch of a therapy in multiple sclerosis
• Proven track record building a marketing organization and brand strategy from the ground up ahead of a first commercial launch
• Experience managing global or multi-market brand positioning, balancing core brand consistency with local market needs
• Strong experience managing external agency partners across creative, media, digital, and market research
• Demonstrated ability to translate clinical and scientific data into clear, differentiated brand positioning and messaging
• Experience partnering closely with Market Access, Medical Affairs, and Patient Advocacy functions on integrated launch strategy
• Comfort operating in a lean, fast-moving, pre-commercial biotech environment
• Willingness and ability to travel approximately 25–35% of the time, including internationally
• Experience launching a therapy with a novel mechanism of action or first-in-class positioning
• Existing relationships within the global MS clinical, scientific, and advocacy community
• Experience operating across both U.S. and European commercial environments
• Familiarity with digital and omnichannel marketing approaches specific to specialty/rare disease brands

About us

Immunic is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases. The company’s lead program, vidofludimus calcium, is currently in phase 3 clinical trials for the treatment of relapsing multiple sclerosis, with therapeutic activity shown in phase 2 clinical trials in relapsing-remitting multiple sclerosis, progressive multiple sclerosis and other diseases. The development pipeline also includes earlier-stage programs addressing neurodegenerative, chronic inflammatory, and autoimmune-related diseases. For further information, please visit: .